BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28612546)

  • 1. [Quality Control and Biological Assessment of Automated Synthesized 3'-deoxy-3'-¹⁸F-fluorothymidine using CFN-MPS-200 Module].
    Jiang X; Wang XX; Lu H; Chen SR; Xiao DQ; Zhao M; Li XL; Zhang G; Xu GH; Cheng ZZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):295-298. PubMed ID: 28612546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated radiochemical synthesis of pharmaceutical grade [
    Mitra A; Chakraborty A; Upadhye T; Tawate M; Lad S; Sahu S; Rajesh C; Bagul S; Pawar Y; Ray MK; Banerjee S
    J Labelled Comp Radiopharm; 2022 Jun; 65(8):206-222. PubMed ID: 35466460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and highly efficient synthesis of 3'-deoxy-3'-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent.
    Lee SJ; Oh SJ; Chi DY; Kil HS; Kim EN; Ryu JS; Moon DH
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1406-9. PubMed ID: 17384949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-yielding, automated production of 3'-deoxy-3'-[(18)F]fluorothymidine using a modified Bioscan Coincidence FDG reaction module.
    Cheung YY; Nickels ML; McKinley ET; Buck JR; Manning HC
    Appl Radiat Isot; 2015 Mar; 97():47-51. PubMed ID: 25531913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High radiochemical yield synthesis of 3'-deoxy-3'-[18F]fluorothymidine using (5'-O-dimethoxytrityl-2'-deoxy-3'-O-nosyl-beta-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor.
    Yun M; Oh SJ; Ha HJ; Ryu JS; Moon DH
    Nucl Med Biol; 2003 Feb; 30(2):151-7. PubMed ID: 12623114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.
    Javed MR; Chen S; Kim HK; Wei L; Czernin J; Kim CJ; van Dam RM; Keng PY
    J Nucl Med; 2014 Feb; 55(2):321-8. PubMed ID: 24365651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Optimized Synthesis of [
    Fedorova OS; Orlovskaya VV; Krasikova RN
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiautomatic synthesis of 3'-deoxy-3'-[18F]fluorothymidine using three precursors.
    Teng B; Wang S; Fu Z; Dang Y; Wu Z; Liu L
    Appl Radiat Isot; 2006 Feb; 64(2):187-93. PubMed ID: 16129604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo.
    Grierson JR; Shields AF
    Nucl Med Biol; 2000 Feb; 27(2):143-56. PubMed ID: 10773543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated synthesis system of 3'-deoxy-3'-[18F]fluorothymidine.
    Oh SJ; Mosdzianowski C; Chi DY; Kim JY; Kang SH; Ryu JS; Yeo JS; Moon DH
    Nucl Med Biol; 2004 Aug; 31(6):803-9. PubMed ID: 15246372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an automated double-synthesis module: efficiency and reliability of subsequent radiosyntheses of FHBG and FLT.
    Niedermoser S; Pape M; Gildehaus FJ; Wängler C; Hartenbach M; Schirrmacher R; Bartenstein P; Wängler B
    Nucl Med Biol; 2012 May; 39(4):586-92. PubMed ID: 22172393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the role of the base in the synthesis of [18F]FLT.
    Suehiro M; Vallabhajosula S; Goldsmith SJ; Ballon DJ
    Appl Radiat Isot; 2007 Dec; 65(12):1350-8. PubMed ID: 17919915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
    Troost EG; Bussink J; Slootweg PJ; Peeters WJ; Merkx MA; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2010 May; 51(5):713-9. PubMed ID: 20395329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.
    Barwick T; Bencherif B; Mountz JM; Avril N
    Nucl Med Commun; 2009 Dec; 30(12):908-17. PubMed ID: 19794320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
    Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
    J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A facile and rapid automated synthesis of 3'-deoxy-3'-[(18)F]fluorothymidine.
    Tang G; Tang X; Wen F; Wang M; Li B
    Appl Radiat Isot; 2010 Sep; 68(9):1734-9. PubMed ID: 20451400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.
    Salskov A; Tammisetti VS; Grierson J; Vesselle H
    Semin Nucl Med; 2007 Nov; 37(6):429-39. PubMed ID: 17920350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.